See All Slides -

Slides

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco

October 31, 2016

$TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock$

Presentation TCT 2016

TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock

Presenter: Tanveer Rab, Richard Smalling, Chi-Cheng Huang

October 31, 2016

Presentation TCT 2016

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Presenter: Sriram S. Iyer, Craig M. Walker, Daniel Ortiz

October 31, 2016

Presentation TCT 2016

TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs Wire Escalation Techniques

Presenter: Christopher E. Buller, Sudhir Rathore, Lorenzo Azzalini

October 31, 2016

Presentation TCT 2016

TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making

Presenter: Daniel S. Berman, Pamela S. Douglas, Justin E. Davies

October 31, 2016

Presentation TCT 2016

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Ramin Ebrahimi

October 31, 2016

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis From 7 Randomized Trials

Presentation TCT 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Advertisement

Slides

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs Wire Escalation Techniques

TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content